Literature DB >> 17337056

Prion protein activates and fixes complement directly via the classical pathway: implications for the mechanism of scrapie agent propagation in lymphoid tissue.

Daniel A Mitchell1, Louise Kirby, Susan M Paulin, Christian L Villiers, Robert B Sim.   

Abstract

C1q-deficient and complement depleted mice are highly resistant to intraperitoneal scrapie infection. The molecular mechanisms of complement involvement in scrapie pathogenesis remain unclear. Previous detailed studies have indicated mouse prion protein interactions with human C1q but the question of subsequent complement activation has remained unaddressed. In this investigation, murine prion protein, both recombinant and also from diseased tissue sources, directly activated and fixed complement via the classical but not the alternative pathway. The importance of complexed cupric ions was observed. In addition, evidence of IgG-independent C4 fixation by prion proteins was also shown. Surface plasmon resonance binding studies using variously clustered immobilized recombinant mouse prion protein indicated strong interactions with both purified mouse C1q and also mouse Factor H. Binding, especially by C1q, was dependent upon the volume of immobilized prion protein, suggesting a threshold of clustering density required to support strong interactions. Furthermore, clustered immobilized prion protein appeared capable of promoting polymerization of soluble-phase monomeric prion protein. Direct covalent attachment of complement components to prion proteins via classical pathway activation illustrates a potential mechanism underpinning their trafficking to, and subsequent propagation within, lymphoid tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337056     DOI: 10.1016/j.molimm.2006.12.027

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  Spreading of prions from the immune to the peripheral nervous system: a potential implication of dendritic cells.

Authors:  Gauthier Dorban; Valérie Defaweux; Ernst Heinen; Nadine Antoine
Journal:  Histochem Cell Biol       Date:  2010-03-18       Impact factor: 4.304

Review 2.  Therapeutic potential of complement modulation.

Authors:  Eric Wagner; Michael M Frank
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

3.  Contribution of follicular dendritic cells to persistent HIV viremia.

Authors:  Jingshan Zhang; Alan S Perelson
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

4.  Alternative complement pathway is activated in the brains of scrapie-infected rodents.

Authors:  Cao Chen; Yan Lv; Chao Hu; Xiao-Feng Xu; Ren-Qing Zhang; Kang Xiao; Yue Ma; Li-Ping Gao; Jian-Le Li; Qiang Shi; Jing Wang; Qi Shi; Xiao-Ping Dong
Journal:  Med Microbiol Immunol       Date:  2019-11-12       Impact factor: 3.402

5.  Reaction of complement factors varies with prion strains in vitro and in vivo.

Authors:  Rie Hasebe; Gregory J Raymond; Motohiro Horiuchi; Byron Caughey
Journal:  Virology       Date:  2012-01-03       Impact factor: 3.616

6.  Genetic depletion of complement receptors CD21/35 prevents terminal prion disease in a mouse model of chronic wasting disease.

Authors:  Brady Michel; Adam Ferguson; Theodore Johnson; Heather Bender; Crystal Meyerett-Reid; Bruce Pulford; Adriana von Teichman; Davis Seelig; John H Weis; Glenn C Telling; Adriano Aguzzi; Mark D Zabel
Journal:  J Immunol       Date:  2012-09-21       Impact factor: 5.422

7.  Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.

Authors:  Anna Bartoletti-Stella; Patrizia Corrado; Nicola Mometto; Simone Baiardi; Pascal F Durrenberger; Thomas Arzberger; Richard Reynolds; Hans Kretzschmar; Sabina Capellari; Piero Parchi
Journal:  Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.590

8.  Complement Regulatory Protein Factor H Is a Soluble Prion Receptor That Potentiates Peripheral Prion Pathogenesis.

Authors:  Sarah J Kane; Taylor K Farley; Elizabeth O Gordon; Joshua Estep; Heather R Bender; Julie A Moreno; Jason Bartz; Glenn C Telling; Matthew C Pickering; Mark D Zabel
Journal:  J Immunol       Date:  2017-10-25       Impact factor: 5.422

Review 9.  The role of complement in tumor growth.

Authors:  Ruben Pio; Leticia Corrales; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 10.  Innate immunity and neuroinflammation.

Authors:  Abhishek Shastri; Domenico Marco Bonifati; Uday Kishore
Journal:  Mediators Inflamm       Date:  2013-06-15       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.